Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.
about
Metabolic factors and chronic hepatitis C: a complex interplayEstimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionFemale gender in the setting of liver transplantationImpact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infectionProgression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysisReproductive status is associated with the severity of fibrosis in women with hepatitis C.The history of the "natural history" of hepatitis C (1968-2009).Effect of common neuropathologies on progression of late life cognitive impairmentChanges in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studiesImpact of HCV genetic differences on pathobiology of disease.Influence of age and gender before and after liver transplantation.The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation.Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysisFuture complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study.Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection.Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis.Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C.
P2860
Q27011787-4A81EB0C-1554-470D-B5A1-97AB7A2B3B40Q27485372-244E7CEF-A2B6-41BA-B4D6-AC05FF1988B8Q28087784-BE6BCA65-92E9-4E31-A00B-40A0AA4CACCDQ33603248-9BE1CEBE-F13F-41A4-9F83-C1EA47D405D3Q33921088-F890775C-8ED7-4713-A1B1-652047330F50Q34412627-B569A605-547A-4A66-87C7-0D919FB28C01Q35216592-35A9B3C3-98D8-4E20-BD9C-4B232A50AC54Q35688596-CDD1D932-8EF9-460B-9A12-49CD214386BCQ36506294-D947DE72-B03D-45AA-8298-AB1B59B68994Q36761430-968C90E4-5B14-4899-ADE4-327AEBF116B8Q37929753-36923644-23D1-4EDD-A6C8-39D7714814C0Q38061619-AD072839-507E-4FB9-A1B6-EBDEFF66E495Q39064153-ACF036AA-D547-4B61-B061-07A0806E9FEBQ40590610-C29BDE1C-2D4D-4DCB-B02D-6857834778CAQ40851782-032A9BF8-7782-45D7-BDC2-E715BF4717E6Q41008122-6E05EEDC-A270-43DA-8DA5-734953F3FEC2Q41711879-B8028481-2C7C-4440-824C-1DE58A2D9AC7Q43040026-6760AF62-937E-4F3E-B571-4C730CD0B527Q45671047-EC1902C9-7408-4B8F-8303-D3BF6496A6E0Q50556008-AA45B966-74F2-4691-9690-6CD5BD691768Q53064039-B5BD1C9D-6F4B-43E4-BB8B-4C67976A2771
P2860
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Quantification of fibrosis pro ...... atitis C using a Markov model.
@en
Quantification of fibrosis pro ...... atitis C using a Markov model.
@nl
type
label
Quantification of fibrosis pro ...... atitis C using a Markov model.
@en
Quantification of fibrosis pro ...... atitis C using a Markov model.
@nl
prefLabel
Quantification of fibrosis pro ...... atitis C using a Markov model.
@en
Quantification of fibrosis pro ...... atitis C using a Markov model.
@nl
P2860
P1476
Quantification of fibrosis pro ...... atitis C using a Markov model.
@en
P2093
Deuffic-Burban S
Valleron AJ
P2860
P304
P356
10.1046/J.1365-2893.2002.00340.X
P577
2002-03-01T00:00:00Z